CD8A and laryngotracheoesophageal cleft: Furthermore, SARS-CoV-2-specific CD8+ T cells of LC patients with active symptoms 12 months after acute disease showed higher CD25 expression compared to convalescent individuals, unlike their IAV-specific CD8+ T cell counterparts (Supplementary Fig. 7d).